2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid

CAS : 594839-88-0

Ref. 3D-FD27988

Informations sur le produit

• Nom: 2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid
• Synonymes: TafamidisFx 1006

Description

2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid (XZP) is a diagnostic agent used in the diagnosis of certain diseases. XZP binds to the matrix metalloproteinases and inhibits their activity, which has been shown to reduce the effects of these enzymes on collagen fibers. This inhibition can be demonstrated using a titration calorimetry technique. The drug is also a potential therapeutic agent for congestive heart failure, as it can stimulate cardiac natriuretic peptide levels and reduce transthyretin levels. XZP has also been shown to be an effective adjunct therapy in vancomycin therapy for treatment of tubulointerstitial injury in rats.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 308.12 g/mol
• Formule: C₁₄H₇Cl₂NO₃
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder
• InChI: InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)
• Code InChI: InChIKey=TXEIIPDJKFWEEC-UHFFFAOYSA-N
• SMILES: O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1